Latest news
Alector, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 22:11:56 GMTAlector, Inc. 2Q 2026: Revenue $3.32M, EPS $(0.21) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTALEC: Advanced ABC platform pipeline and reduced net loss, with cash runway through 2027 - TradingViewTradingView · Thu, 06 Aug 2026 20:26:22 GMTALEC: Revenue and expenses fell as clinical programs ended; cash runway extends through 2027 - TradingViewTradingView · Thu, 06 Aug 2026 20:17:56 GMTAlector reports Q2 2026: $172.8M cash; Q2 net loss $23.0M - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTALEC|Alector Inc|Price:1.520|Chg%:+0.010 - TradingKeyTradingKey · Tue, 04 Aug 2026 09:31:13 GMTALEC: Brain carrier platform enables next-gen CNS therapies with superior brain delivery and safety - TradingViewTradingView · Sat, 01 Aug 2026 07:00:00 GMTEnterprise value to EBITDA forward of Alector, Inc. – NASDAQ:ALEC - TradingViewTradingView · Sat, 01 Aug 2026 05:54:29 GMT